Now people can purchase Vicks Action 500, Corex cough syrup as HC cancels ban

Author yuvamind

NEW DELHI: Delhi High Court stayed on Thursday a government ban on 344 drugs that it cognize lacked therapeutic dominance, after over six months of hearing more than 300 petitions which were filed by drugmakers against it. The drug brands included D ' Cold Total, Corex cough syrup, and Vicks Action 500, among others.
Justice RS Endlaw, affirming the 454 petitions filed by the pharma companies, quashed the Centre ' s notification issued on 10 March 2016. Companies like Pfizer, Glenmark, Procter and Gamble, Reckitt Benckiser, Cipla and others had moved the court against the government decision. As the Delhi high court had granted stay on the notification. Thursday ' s decision provides interim relief to several local and multinational drugmakers operating in India ' s $15 billion drugs industry whose business had been hit by the ban. Many, however, had obtained stay orders days after the ban was announced in March. The move covered fixed-dose combination drugs, which are cocktails of medicines that are used worldwide to improve patients ' compliance in complicated courses of treatment, especially for conditions such as HIV, tuberculosis and malaria. The government announced the ban in March saying extensive deliberations with scientific experts had found the medicines lacked therapeutic efficacy. Most companies filed petitions arguing the government did not exercise its powers appropriately. The reversal of the ban means companies can continue to sell these drugs. The decision is another setback for India ' s efforts to weed out irrational fixed-dose combination drugs from the market. A similar move in 2007 to ban about 294 such drugs was also met with stiff resistance from the industry, which obtained a stay.
SUBSCRIBE YUVAMIND NEWSLETTER
COPYRIGHT © 2024 YUVAMIND. ALL RIGHTS RESERVED. THE LOGOS/IMAGES ARE SHOWN ON THIS WEBSITE BELONG TO THE RESPECTIVE OWNERS / PATNERS.
Disclaimer: Yuvamind doesn't provide admission on its own, the website has published the details are based on research OR provided by the second party to help the aspirants, If you find inappropriate contents on this website please tell us, your suggestions shall be highly appreciated.